DGAP-News 312 0 Kommentare MeVis Medical Solutions AG: New agreement with Hologic pointing the way forward

DGAP-News: MeVis Medical Solutions AG / Key word(s): Contract/Alliance
MeVis Medical Solutions AG: New agreement with Hologic pointing the
way forward

25.09.2014 / 18:00

---------------------------------------------------------------------

MeVis and Hologic set the course for further future cooperation

- Contract negotiations successfully completed

- Cooperation agreement between MeVis and Hologic on development support

Bremen, September 25, 2014 - MeVis Medical Solutions AG [ISIN:
DE000A0LBFE4], a leading provider of medical imaging software, announces
that it has entered into a collaborative software development agreement
with its largest customer Hologic, Inc., a leading developer, manufacturer
and supplier of premium diagnostic products, medical imaging systems and
surgical products. The agreement relates to the development of software
applications for certain of Hologic's mammography products.

This is the second contract between MeVis and Hologic in 2014. Earlier this
year MeVis announced that the parties had agreed to extend the previous
software licensing agreement through the end of 2015 with amended terms.
The current licensing and maintenance business with Hologic is expected to
gradually be converted to one of development support.

"We are pleased to be entering into a new collaboration with our
long-standing customer Hologic. We believe this agreement validates our
reputation and excellent market position of MeVis Medical Solutions AG in
the area of product software used for breast cancer screening, diagnosis,
and treatment. With over 10,000 licenses sold worldwide in the areas of
mammography, tomosynthesis, breast MR, intervention and breast ultrasound
diagnosis, MeVis is the global market leader and we are keen to further
expand our position." said Marcus Kirchhoff, CEO of MeVis Medical Solutions
AG.

"The agreement now, in connection with the extension of the existing
license agreement until the end of 2015 already signed in February,
increases our visibility on future revenues." added Dr. Robert Hannemann,
CFO of MeVis Medical Solutions AG. "Our commercial expectations published
in January 2014 could be fully met by the new contract."

---------------------------------------------------------------------

25.09.2014 Dissemination of a Corporate News, transmitted by DGAP - a
service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------

Language: English
Company: MeVis Medical Solutions AG
Caroline-Herschel-Str. 1
28359 Bremen
Germany
Phone: +49 421 224 95 0
Fax: +49 421 224 95 999
E-mail: ir@mevis.de
Internet: http://www.mevis.de
ISIN: DE000A0LBFE4
WKN: A0LBFE
Listed: Regulierter Markt in Frankfurt (Prime Standard);
Freiverkehr in Berlin, Düsseldorf, München, Stuttgart

End of News DGAP News-Service
---------------------------------------------------------------------
288836 25.09.2014